Meta ordered to sell Giphy as UK competition watchdog confirms decision | The Independent
UK Watchdog Group Accuses Pfizer, Flynn Pharma of Price Gouging on Epilepsy Drug | BioSpace
CMA Investigation Into Pharmaceutical Industry For Steep Price Increase
Pfizer epilepsy drug prices were 'unfairly high,' UK review finds | Reuters
U.K. watchdog smacks Pfizer with record fine, citing a 2,600% price hike | Fierce Pharma
After 10,000% price hike, pharma companies face $350M-plus fine in U.K. | Fierce Pharma
How can competition authorities tackle price rises in a crisis? - Economics Observatory
CMA fines Advanz over 'excessive and unfair' pricing of thyroid drug - PharmaTimes
Advanz Hits Back Over £100m+ Fines For UK Liothyronine Pricing :: Pink Sheet
CMA won't launch a full market investigation of streaming and the music industry - Music Ally
Four drug companies accused of illegal market sharing
UK's CMA Issues Fines Over Fludrocortisone :: Medtech Insight
Generic drug price increases of up to 1,700% have cost the NHS £76m - The Pharmaceutical Journal
Antitrust Developments in the Pharma Sector, Part II - Competition Law Insight
Competition and Markets Authority - Wikipedia
Setback for CMA in £90m appeal case against big pharma :: C+D
CMA fines pharma firm over pricing of crucial thyroid drug - GOV.UK
PDF) The economics of potential price gouging during Covid-19 and the application to complaints received by the CMA
Competition watchdog fines pharma firm over pricing of crucial thyroid drug | The Independent
UK's CMA Issues £35m In Fines Over Prochlorperazine :: Pink Sheet
Pfizer fined $106M for 2600% price hike on epilepsy drug
Pricing of oral generic cancer medicines in 25 European countries; findings and implications - GaBI Journal
Big pharma fined £35m by competition regulator over NHS drug prices
